APPLIED GENETIC TECHNOLOGIES CORP — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/bce96d89-e2d1-4163-811f-e34db90640b7/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $325.0k | 2021-07-01 – 2022-06-30 | evidence 0001193125-22-252231 |
| FY 2021 | $500.0k | 2020-07-01 – 2021-06-30 | evidence 0001193125-21-280686 |
| FY 2020 | $2.5M | 2019-07-01 – 2020-06-30 | evidence 0001193125-20-249103 |
| FY 2019 | $41.7M | 2018-07-01 – 2019-06-30 | evidence 0001193125-19-255968 |
| FY 2018 | $24.2M | 2017-07-01 – 2018-06-30 | evidence 0001193125-19-255968 |
| FY 2017 | $39.5M | 2016-07-01 – 2017-06-30 | evidence 0001564590-17-018636 |
| FY 2016 | $47.4M | 2015-07-01 – 2016-06-30 | evidence 0001564590-16-025119 |
| FY 2015 | $2.4M | 2014-07-01 – 2015-06-30 | evidence 0001564590-15-007858 |
| FY 2014 | $1.1M | 2013-07-01 – 2014-06-30 | evidence 0001193125-14-354838 |
| FY 2013 | $942.0k | 2012-07-01 – 2013-06-30 | evidence 0001193125-14-354838 |
| FY 2012 | $1.1M | 2011-07-01 – 2012-06-30 | evidence 0001193125-14-354838 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
APPLIED GENETIC TECHNOLOGIES CORP — all facts · Net Income · Operating Income